Dayama, Bb Girl .
HRN: 28-66-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2026
AMPICILLIN 250MG (VIAL)
03/07/2026
03/14/2026
IVTT
165mg
Q12h
PSNB
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: